Happy Holidays from all of us at ISLB! ✨ As we wrap up an incredible year in liquid biopsy research, we extend our heartfelt gratitude to our community of scientists, clinicians, and innovators. Thank you for your dedication and contributions! Here’s to a joyful holiday season and an exciting year ahead. See you at #ISLB25 in Miami from November 1-3, 2025! #HappyHolidays #LiquidBiopsy #ISLB Christian Rolfo, MD, PhD, MBA,Dr.hc Mª JOSE SERRANO Umberto Malapelle Eloisa Jantus Massimo Cristofanilli, MD, FACP
International Society of Liquid Biopsy
Organizaciones sin ánimo de lucro
Granada, Andalusia 3301 seguidores
International professional organization committed to the advancement of the Liquid Biopsy.
Sobre nosotros
Founded in 2017 in the city of Granada, in Spain and with a global reach: by joining those professionals mainly oncology and specialties related to the use of liquid biopsies as a new clinical tool. We welcome, therefore, to the professionals of the liquid biopsy of the world. We want to be the link of all stakeholders in the LB theme, connecting professionals with diverse experience and experience and speaking with one voice for our discipline. Our education and information resources support an integrated multiprofessional approach for advancing cancer research in particular and medical in general... We seek to erase the limits that determine the restriction of the LB implementation in the usual clinical practice, either between countries or specialties, and with the objective to group and unite efforts in the research of the LB around the world.
- Sitio web
-
https://www.islb.info
Enlace externo para International Society of Liquid Biopsy
- Sector
- Organizaciones sin ánimo de lucro
- Tamaño de la empresa
- De 11 a 50 empleados
- Sede
- Granada, Andalusia
- Tipo
- Organización sin ánimo de lucro
- Fundación
- 2017
Ubicaciones
-
Principal
Avenida del Doctor Olóriz
16
Granada, Andalusia 18012, ES
Empleados en International Society of Liquid Biopsy
Actualizaciones
-
International Society of Liquid Biopsy ha compartido esto
Highlights from ISLB 2024: Exploring the Future of Liquid Biopsy The 6th Annual Congress of the International Society of Liquid Biopsy (ISLB), held in Denver, Colorado from November 23-25, 2024, brought together global experts to explore the latest advancements in liquid biopsy technology. The congress featured keynotes, panel discussions, and presentations focused on integrating liquid biopsy for cancer diagnosis, monitoring, and treatment. Attendees had the opportunity to collaborate and share insights on innovative, non-invasive technologies aimed at improving patient outcomes. Christian Rolfo, MD, PhD, MBA,Dr.hc Yüksel ÜRÜN Simon Patton Mariantonia Nacchio Bruna Pellini Daniel Sumarriva, M.D.Nadia Ghazali Mariantonia Nacchio Roberto Borea Björn Nowack Carlos Pedraz Biljana Naumovic Jacob Berchuck Eleonora Nicolò https://lnkd.in/ewdjcf-K #OncoDaily #Oncology #Cancer #Health #Medicine #LiquidBiopsy #CancerCare #HealthCare
-
Attending ISLB 2024 in Denver USA? Precision Cancer Consortium (PCC) are thrilled to invite you to attend a sponsored symposium entitled “Expanding access and adoption of liquid biopsy in routine clinical care: Expert insights, practical solutions, and your chance to join the conversation”. This symposium will take place on Saturday 23rd November ,12:45 in the Adams B meeting room. Come along to hear from @Dr Simon Heeke, @Prof Paul Hofman and @Dr Bruna Pellini as we explore more about PCC, hear what the experts have to say about improving patient access to comprehensive genomic profiling, and what we can all do to make a difference. PCC look forward to seeing you in Denver! This event is organized and funded by the PCC. The PCC is a non-profit organization dedicated to driving global access to comprehensive genomic testing for all patients with cancer. The PCC is composed of and funded by: AstraZeneca, Bayer, GSK, Johnson & Johnson, Lilly, Novartis, and Roche, at the time of writing. PCC-107 Date of preparation: November 2024
-
#ISLB24 Kicks Off Tomorrow! 🎉 We’re thrilled to welcome you to Denver, Colorado, for an incredible gathering of #LiquidBiopsy experts. Get ready for an engaging program packed with insightful sessions, cutting-edge research, and networking opportunities. Have questions about the Congress? Visit our Onsite Information page for details on the venue, program, and more: https://lnkd.in/gND_DFWc We can’t wait to see you there! Christian Rolfo, MD, PhD, MBA,Dr.hc Mª JOSE SERRANO Umberto Malapelle Eloisa Jantus Massimo Cristofanilli, MD, FACP
-
Meet Augusto Villanueva at #ISLB24! Augusto Villanueva is Associate Professor in Icahn School of Medicine at Mount Sinai, New York. He received his medical degree from the University of Santiago de Compostela (Spain). Register Now at https://lnkd.in/exfr-3xC #LiquidBiopsy #SpeakerHighlight Christian Rolfo, MD, PhD, MBA,Dr.hc Mª JOSE SERRANO Umberto Malapelle Eloisa Jantus Massimo Cristofanilli, MD, FACP
-
Regular Registration Ends Today! 📢 Time is running out! Just a few hours left to save on registration for #ISLB24. Don’t miss your chance to join us in Denver, Colorado, from November 23-25, 2024, and connect with leading experts in #LiquidBiopsy. Can’t attend in person? No worries! Register for On Demand access and explore the sessions from anywhere in the world. Register by November 15 (23:59 CEST) at https://lnkd.in/eyN5D5t2 Christian Rolfo, MD, PhD, MBA,Dr.hc Mª JOSE SERRANO Umberto Malapelle Eloisa Jantus Massimo Cristofanilli, MD, FACP
-
Regular Registration for #ISLB24 is closing tomorrow, November 15! ⏰ This is your last chance to save on registration rates and ensure your place at the 6th Annual Congress of Liquid Biopsy in Denver or to access valuable sessions on demand from anywhere. 👉 Register Now at https://lnkd.in/eyN5D5t2 Christian Rolfo, MD, PhD, MBA,Dr.hc Mª JOSE SERRANO Umberto Malapelle Eloisa Jantus Massimo Cristofanilli, MD, FACP
-
Don't Miss the ctDNA: Preanalytical and Post Analytical Standardization Workshop! Join us on Sunday, November 24, 2024, from 13:30 - 15:00 at Spruce 3-4 as we work to establish consensus on key aspects of ctDNA assessment, covering pre-analytical, analytical, and post-analytical phases. Our panelists will tackle pressing questions such as: 👉 How to accurately assess tumor fraction? 👉 How can NGS panels be designed to detect key mutations at low allele frequencies with high specificity? 👉 What are the best algorithms and bioinformatics pipelines for interpreting mutations identified in ctDNA? Chaired by Eloisa Jantus and Nicola Fusco, this workshop offers a valuable opportunity to deepen your understanding and gain fresh insights from field-leading experts. Read More at https://lnkd.in/eSY69xPb #ctDNA #NGS #Bioinformatics #OncologyWorkshop
-
Meet Adam Sowalsky at #ISLB24! Dr. Sowalsky is a Senior Investigator in the Intramural Research Program of the NIH, in the Genitourinary Malignancies Branch of the National Cancer Institute. His laboratory conducts translational research to identify biomarkers and mechanisms of disease progression and treatment resistance in patients with advanced prostate cancer. Register Now at https://lnkd.in/exfr-3xC #LiquidBiopsy #SpeakerHighlight Christian Rolfo, MD, PhD, MBA,Dr.hc Mª JOSE SERRANO Umberto Malapelle Eloisa Jantus Massimo Cristofanilli, MD, FACP
-
⏳ Time is Running Out! Regular Registration for #ISLB24 ends this Friday, November 15! Whether joining in person or on demand, this is your chance to connect with leading experts in #liquidbiopsy and stay at the forefront of this rapidly advancing field. 👉 Register Now at https://lnkd.in/eyN5D5t2 Christian Rolfo, MD, PhD, MBA,Dr.hc Mª JOSE SERRANO Umberto Malapelle Eloisa Jantus Massimo Cristofanilli, MD, FACP